English

    Overview

  • Dr. Mohit Chowdhury is a highly qualified and dedicated specialist in the field of Infectious Diseases, Adult Immunization, and Travel Medicine. He laid the foundation of his medical career at the historic Medical College, Kolkata, where he earned his MBBS degree in 2018. Demonstrating a deep commitment to clinical excellence, he went on to pursue his advanced super-specialization, earning a prestigious DM in Infectious Diseases from the premier All India Institute of Medical Sciences (AIIMS), New Delhi, in 2025. Registered with the Delhi Medical Council since 2019, Dr. Chowdhury brings cutting-edge clinical training and a compassionate approach to patient care.

  • Dr. Chowdhury specializes in diagnosing, managing, and treating a wide spectrum of complex infectious diseases, ranging from acute seasonal infections to chronic, drug-resistant pathogens. With advanced training from AIIMS, he is highly skilled in navigating challenging clinical cases, including healthcare-associated infections, fungal diseases, and infections in immunocompromised individuals. In addition to treatment, he is a strong advocate for preventive healthcare, offering specialized consultations in adult immunization to protect individuals against preventable diseases.

  • Recognizing the complexities of global travel, Dr. Chowdhury also excels in travel medicine, providing essential pre-travel counseling, personalized vaccination plans, and post-travel health evaluations to safeguard travelers heading to diverse geographical regions. His practice combines the latest scientific research with an empathetic, patient-first philosophy, ensuring that each individual receives a comprehensive and tailored management plan.

  • Beyond direct patient care, Dr. Chowdhury is deeply invested in promoting antimicrobial stewardship, helping to combat the global threat of drug resistance by ensuring the rational and judicious use of antibiotics. His rigorous academic background and extensive hands-on residency experience in India's leading tertiary care facility enable him to manage complex outpatient consultations as well as critical ICU-level infectious emergencies with equal precision. Dr. Chowdhury remains committed to improving public health and helping his patients navigate complex health challenges with confidence, scientific clarity, and unmatched clinical dedication.

  • Field of Expertise

  • Pyrexia of unknown origin
  • Bone & Joint Infections
  • Transplant Infections
  • HIV-AIDS
  • Primary Immunodeficiencies
  • Adult Vaccination
  • Travel Medicine
  • Chemo-Immuno prophylaxis
  • Anti-Microbial Stewardship
  • Hospital acquired infections
  • Hospital Infection Control
  • Sexually Transmitted Diseases
  • Tuberculosis
  • Viral Infections
  • Fungal Infections
  • Fellowship & Membership

  • Clinical Infectious Diseases Society Of India
  • European Society Of Clinical Microbiology & Infectious Diseases
  • Infectious Disease Society Of America
  • Delhi Medical Association
  • Languages Spoken

  • Hindi
  • English
  • Bengali
  • Awards & Achievements

  • Gold Medalist – DM (Infectious Diseases), All India Institute of Medical Sciences (AIIMS), New Delhi, 2025
  • MRCP (UK) – Part 2, Royal Colleges of Physicians of the United Kingdom
  • ESCMID Global Top 50 Observership, Oxford University Hospitals, United Kingdom, 2024
  • Global Investigator Award, LMCE 2022, Seoul, South Korea
  • ANRF-ITS Grant, Government of India, for IDWeek, Los Angeles, USA, 2024
  • Resource Person, Contagion, 2026
  • Guest Speaker, LTSICON, 2025
  • Resource Person Honour, ASPICON 2021 (Antimicrobial Stewardship)
  • Pan & Basak Memorial Award for Anatomy, Medical College Kolkata, 2013
  • Talks & Publications

  • The Utility of Galactomannan and PCR Assays in BAL for Diagnosis of Chronic Pulmonary Aspergillosis, Chowdhury M, Singh G, et al. Mycopathologia, 2023, 188(6): 1041–1053.
  • Efficacy of LD Bio Aspergillus ICT Lateral Flow Assay for Serodiagnosis of Chronic Pulmonary Aspergillosis, Ray A,Chowdhury M, et al. Journal of Fungi (Basel), 2022, 8(4): 400.
  • Clinical predictors of long COVID-19 and phenotypes of mild COVID-19 at a tertiary care centre in India, Chopra N,Chowdhury M, et al. Drug Discoveries & Therapeutics, 2021, 15(3): 156–161.
  • Clinicomicrobiological profile of patients with Stenotrophomonas maltophilia infections, Arunan B, Priyadarshi M, Chowdhary M, Chowdhury S, Mohapatra S, Sood S, Das BK, Wig N, Soneja M. Indian Journal of Medical Microbiology, 2026, 63, 101200. doi:10.1016/j.ijmmb.2026.101200
  • Acanthamoeba meningoencephalitis causing secondary HLH in an immunocompetent patient: a first case report,Chowdhury M, Prakash PR, et al. Journal of the Royal College of Physicians of Edinburgh, 2023, 53(1): 23–26.
  • COVID-19: Immunology & Therapeutics, Chowdhury M, Pant S, Mahishi N, Soneja M, Wig N. COVID-19 Immunology and Therapeutics, Meditropics, 2025.
  • Contributor – Gastrointestinal TB Section, WHO Training Module on Extrapulmonary Tuberculosis, World Health Organization

    Fellowship & Membership

  • Clinical Infectious Diseases Society Of India
  • European Society Of Clinical Microbiology & Infectious Diseases
  • Infectious Disease Society Of America
  • Delhi Medical Association
  • Overview

  • Dr. Mohit Chowdhury is a highly qualified and dedicated specialist in the field of Infectious Diseases, Adult Immunization, and Travel Medicine. He laid the foundation of his medical career at the historic Medical College, Kolkata, where he earned his MBBS degree in 2018. Demonstrating a deep commitment to clinical excellence, he went on to pursue his advanced super-specialization, earning a prestigious DM in Infectious Diseases from the premier All India Institute of Medical Sciences (AIIMS), New Delhi, in 2025. Registered with the Delhi Medical Council since 2019, Dr. Chowdhury brings cutting-edge clinical training and a compassionate approach to patient care.

  • Dr. Chowdhury specializes in diagnosing, managing, and treating a wide spectrum of complex infectious diseases, ranging from acute seasonal infections to chronic, drug-resistant pathogens. With advanced training from AIIMS, he is highly skilled in navigating challenging clinical cases, including healthcare-associated infections, fungal diseases, and infections in immunocompromised individuals. In addition to treatment, he is a strong advocate for preventive healthcare, offering specialized consultations in adult immunization to protect individuals against preventable diseases.

  • Recognizing the complexities of global travel, Dr. Chowdhury also excels in travel medicine, providing essential pre-travel counseling, personalized vaccination plans, and post-travel health evaluations to safeguard travelers heading to diverse geographical regions. His practice combines the latest scientific research with an empathetic, patient-first philosophy, ensuring that each individual receives a comprehensive and tailored management plan.

  • Beyond direct patient care, Dr. Chowdhury is deeply invested in promoting antimicrobial stewardship, helping to combat the global threat of drug resistance by ensuring the rational and judicious use of antibiotics. His rigorous academic background and extensive hands-on residency experience in India's leading tertiary care facility enable him to manage complex outpatient consultations as well as critical ICU-level infectious emergencies with equal precision. Dr. Chowdhury remains committed to improving public health and helping his patients navigate complex health challenges with confidence, scientific clarity, and unmatched clinical dedication.

  • Field of Expertise

  • Pyrexia of unknown origin
  • Bone & Joint Infections
  • Transplant Infections
  • HIV-AIDS
  • Primary Immunodeficiencies
  • Adult Vaccination
  • Travel Medicine
  • Chemo-Immuno prophylaxis
  • Anti-Microbial Stewardship
  • Hospital acquired infections
  • Hospital Infection Control
  • Sexually Transmitted Diseases
  • Tuberculosis
  • Viral Infections
  • Fungal Infections
  • Languages Spoken

  • Hindi
  • English
  • Bengali
  • Awards & Achievements

  • Gold Medalist – DM (Infectious Diseases), All India Institute of Medical Sciences (AIIMS), New Delhi, 2025
  • MRCP (UK) – Part 2, Royal Colleges of Physicians of the United Kingdom
  • ESCMID Global Top 50 Observership, Oxford University Hospitals, United Kingdom, 2024
  • Global Investigator Award, LMCE 2022, Seoul, South Korea
  • ANRF-ITS Grant, Government of India, for IDWeek, Los Angeles, USA, 2024
  • Resource Person, Contagion, 2026
  • Guest Speaker, LTSICON, 2025
  • Resource Person Honour, ASPICON 2021 (Antimicrobial Stewardship)
  • Pan & Basak Memorial Award for Anatomy, Medical College Kolkata, 2013
  • Talks & Publications

  • The Utility of Galactomannan and PCR Assays in BAL for Diagnosis of Chronic Pulmonary Aspergillosis, Chowdhury M, Singh G, et al. Mycopathologia, 2023, 188(6): 1041–1053.
  • Efficacy of LD Bio Aspergillus ICT Lateral Flow Assay for Serodiagnosis of Chronic Pulmonary Aspergillosis, Ray A,Chowdhury M, et al. Journal of Fungi (Basel), 2022, 8(4): 400.
  • Clinical predictors of long COVID-19 and phenotypes of mild COVID-19 at a tertiary care centre in India, Chopra N,Chowdhury M, et al. Drug Discoveries & Therapeutics, 2021, 15(3): 156–161.
  • Clinicomicrobiological profile of patients with Stenotrophomonas maltophilia infections, Arunan B, Priyadarshi M, Chowdhary M, Chowdhury S, Mohapatra S, Sood S, Das BK, Wig N, Soneja M. Indian Journal of Medical Microbiology, 2026, 63, 101200. doi:10.1016/j.ijmmb.2026.101200
  • Acanthamoeba meningoencephalitis causing secondary HLH in an immunocompetent patient: a first case report,Chowdhury M, Prakash PR, et al. Journal of the Royal College of Physicians of Edinburgh, 2023, 53(1): 23–26.
  • COVID-19: Immunology & Therapeutics, Chowdhury M, Pant S, Mahishi N, Soneja M, Wig N. COVID-19 Immunology and Therapeutics, Meditropics, 2025.
  • Contributor – Gastrointestinal TB Section, WHO Training Module on Extrapulmonary Tuberculosis, World Health Organization

    Languages Spoken

  • Hindi
  • English
  • Bengali
  • Overview

  • Dr. Mohit Chowdhury is a highly qualified and dedicated specialist in the field of Infectious Diseases, Adult Immunization, and Travel Medicine. He laid the foundation of his medical career at the historic Medical College, Kolkata, where he earned his MBBS degree in 2018. Demonstrating a deep commitment to clinical excellence, he went on to pursue his advanced super-specialization, earning a prestigious DM in Infectious Diseases from the premier All India Institute of Medical Sciences (AIIMS), New Delhi, in 2025. Registered with the Delhi Medical Council since 2019, Dr. Chowdhury brings cutting-edge clinical training and a compassionate approach to patient care.

  • Dr. Chowdhury specializes in diagnosing, managing, and treating a wide spectrum of complex infectious diseases, ranging from acute seasonal infections to chronic, drug-resistant pathogens. With advanced training from AIIMS, he is highly skilled in navigating challenging clinical cases, including healthcare-associated infections, fungal diseases, and infections in immunocompromised individuals. In addition to treatment, he is a strong advocate for preventive healthcare, offering specialized consultations in adult immunization to protect individuals against preventable diseases.

  • Recognizing the complexities of global travel, Dr. Chowdhury also excels in travel medicine, providing essential pre-travel counseling, personalized vaccination plans, and post-travel health evaluations to safeguard travelers heading to diverse geographical regions. His practice combines the latest scientific research with an empathetic, patient-first philosophy, ensuring that each individual receives a comprehensive and tailored management plan.

  • Beyond direct patient care, Dr. Chowdhury is deeply invested in promoting antimicrobial stewardship, helping to combat the global threat of drug resistance by ensuring the rational and judicious use of antibiotics. His rigorous academic background and extensive hands-on residency experience in India's leading tertiary care facility enable him to manage complex outpatient consultations as well as critical ICU-level infectious emergencies with equal precision. Dr. Chowdhury remains committed to improving public health and helping his patients navigate complex health challenges with confidence, scientific clarity, and unmatched clinical dedication.

  • Fellowship & Membership

  • Clinical Infectious Diseases Society Of India
  • European Society Of Clinical Microbiology & Infectious Diseases
  • Infectious Disease Society Of America
  • Delhi Medical Association
  • Field of Expertise

  • Pyrexia of unknown origin
  • Bone & Joint Infections
  • Transplant Infections
  • HIV-AIDS
  • Primary Immunodeficiencies
  • Adult Vaccination
  • Travel Medicine
  • Chemo-Immuno prophylaxis
  • Anti-Microbial Stewardship
  • Hospital acquired infections
  • Hospital Infection Control
  • Sexually Transmitted Diseases
  • Tuberculosis
  • Viral Infections
  • Fungal Infections
  • Awards & Achievements

  • Gold Medalist – DM (Infectious Diseases), All India Institute of Medical Sciences (AIIMS), New Delhi, 2025
  • MRCP (UK) – Part 2, Royal Colleges of Physicians of the United Kingdom
  • ESCMID Global Top 50 Observership, Oxford University Hospitals, United Kingdom, 2024
  • Global Investigator Award, LMCE 2022, Seoul, South Korea
  • ANRF-ITS Grant, Government of India, for IDWeek, Los Angeles, USA, 2024
  • Resource Person, Contagion, 2026
  • Guest Speaker, LTSICON, 2025
  • Resource Person Honour, ASPICON 2021 (Antimicrobial Stewardship)
  • Pan & Basak Memorial Award for Anatomy, Medical College Kolkata, 2013
  • Talks & Publications

  • The Utility of Galactomannan and PCR Assays in BAL for Diagnosis of Chronic Pulmonary Aspergillosis, Chowdhury M, Singh G, et al. Mycopathologia, 2023, 188(6): 1041–1053.
  • Efficacy of LD Bio Aspergillus ICT Lateral Flow Assay for Serodiagnosis of Chronic Pulmonary Aspergillosis, Ray A,Chowdhury M, et al. Journal of Fungi (Basel), 2022, 8(4): 400.
  • Clinical predictors of long COVID-19 and phenotypes of mild COVID-19 at a tertiary care centre in India, Chopra N,Chowdhury M, et al. Drug Discoveries & Therapeutics, 2021, 15(3): 156–161.
  • Clinicomicrobiological profile of patients with Stenotrophomonas maltophilia infections, Arunan B, Priyadarshi M, Chowdhary M, Chowdhury S, Mohapatra S, Sood S, Das BK, Wig N, Soneja M. Indian Journal of Medical Microbiology, 2026, 63, 101200. doi:10.1016/j.ijmmb.2026.101200
  • Acanthamoeba meningoencephalitis causing secondary HLH in an immunocompetent patient: a first case report,Chowdhury M, Prakash PR, et al. Journal of the Royal College of Physicians of Edinburgh, 2023, 53(1): 23–26.
  • COVID-19: Immunology & Therapeutics, Chowdhury M, Pant S, Mahishi N, Soneja M, Wig N. COVID-19 Immunology and Therapeutics, Meditropics, 2025.
  • Contributor – Gastrointestinal TB Section, WHO Training Module on Extrapulmonary Tuberculosis, World Health Organization

    Field of Expertise

  • Pyrexia of unknown origin
  • Bone & Joint Infections
  • Transplant Infections
  • HIV-AIDS
  • Primary Immunodeficiencies
  • Adult Vaccination
  • Travel Medicine
  • Chemo-Immuno prophylaxis
  • Anti-Microbial Stewardship
  • Hospital acquired infections
  • Hospital Infection Control
  • Sexually Transmitted Diseases
  • Tuberculosis
  • Viral Infections
  • Fungal Infections
  • Fellowship & Membership

  • Clinical Infectious Diseases Society Of India
  • European Society Of Clinical Microbiology & Infectious Diseases
  • Infectious Disease Society Of America
  • Delhi Medical Association
  • Languages Spoken

  • Hindi
  • English
  • Bengali
  • Awards & Achievements

  • Gold Medalist – DM (Infectious Diseases), All India Institute of Medical Sciences (AIIMS), New Delhi, 2025
  • MRCP (UK) – Part 2, Royal Colleges of Physicians of the United Kingdom
  • ESCMID Global Top 50 Observership, Oxford University Hospitals, United Kingdom, 2024
  • Global Investigator Award, LMCE 2022, Seoul, South Korea
  • ANRF-ITS Grant, Government of India, for IDWeek, Los Angeles, USA, 2024
  • Resource Person, Contagion, 2026
  • Guest Speaker, LTSICON, 2025
  • Resource Person Honour, ASPICON 2021 (Antimicrobial Stewardship)
  • Pan & Basak Memorial Award for Anatomy, Medical College Kolkata, 2013
  • Talks & Publications

  • The Utility of Galactomannan and PCR Assays in BAL for Diagnosis of Chronic Pulmonary Aspergillosis, Chowdhury M, Singh G, et al. Mycopathologia, 2023, 188(6): 1041–1053.
  • Efficacy of LD Bio Aspergillus ICT Lateral Flow Assay for Serodiagnosis of Chronic Pulmonary Aspergillosis, Ray A,Chowdhury M, et al. Journal of Fungi (Basel), 2022, 8(4): 400.
  • Clinical predictors of long COVID-19 and phenotypes of mild COVID-19 at a tertiary care centre in India, Chopra N,Chowdhury M, et al. Drug Discoveries & Therapeutics, 2021, 15(3): 156–161.
  • Clinicomicrobiological profile of patients with Stenotrophomonas maltophilia infections, Arunan B, Priyadarshi M, Chowdhary M, Chowdhury S, Mohapatra S, Sood S, Das BK, Wig N, Soneja M. Indian Journal of Medical Microbiology, 2026, 63, 101200. doi:10.1016/j.ijmmb.2026.101200
  • Acanthamoeba meningoencephalitis causing secondary HLH in an immunocompetent patient: a first case report,Chowdhury M, Prakash PR, et al. Journal of the Royal College of Physicians of Edinburgh, 2023, 53(1): 23–26.
  • COVID-19: Immunology & Therapeutics, Chowdhury M, Pant S, Mahishi N, Soneja M, Wig N. COVID-19 Immunology and Therapeutics, Meditropics, 2025.
  • Contributor – Gastrointestinal TB Section, WHO Training Module on Extrapulmonary Tuberculosis, World Health Organization
  • Overview

  • Dr. Mohit Chowdhury is a highly qualified and dedicated specialist in the field of Infectious Diseases, Adult Immunization, and Travel Medicine. He laid the foundation of his medical career at the historic Medical College, Kolkata, where he earned his MBBS degree in 2018. Demonstrating a deep commitment to clinical excellence, he went on to pursue his advanced super-specialization, earning a prestigious DM in Infectious Diseases from the premier All India Institute of Medical Sciences (AIIMS), New Delhi, in 2025. Registered with the Delhi Medical Council since 2019, Dr. Chowdhury brings cutting-edge clinical training and a compassionate approach to patient care.

  • Dr. Chowdhury specializes in diagnosing, managing, and treating a wide spectrum of complex infectious diseases, ranging from acute seasonal infections to chronic, drug-resistant pathogens. With advanced training from AIIMS, he is highly skilled in navigating challenging clinical cases, including healthcare-associated infections, fungal diseases, and infections in immunocompromised individuals. In addition to treatment, he is a strong advocate for preventive healthcare, offering specialized consultations in adult immunization to protect individuals against preventable diseases.

  • Recognizing the complexities of global travel, Dr. Chowdhury also excels in travel medicine, providing essential pre-travel counseling, personalized vaccination plans, and post-travel health evaluations to safeguard travelers heading to diverse geographical regions. His practice combines the latest scientific research with an empathetic, patient-first philosophy, ensuring that each individual receives a comprehensive and tailored management plan.

  • Beyond direct patient care, Dr. Chowdhury is deeply invested in promoting antimicrobial stewardship, helping to combat the global threat of drug resistance by ensuring the rational and judicious use of antibiotics. His rigorous academic background and extensive hands-on residency experience in India's leading tertiary care facility enable him to manage complex outpatient consultations as well as critical ICU-level infectious emergencies with equal precision. Dr. Chowdhury remains committed to improving public health and helping his patients navigate complex health challenges with confidence, scientific clarity, and unmatched clinical dedication.

    Awards & Achievements

  • Gold Medalist – DM (Infectious Diseases), All India Institute of Medical Sciences (AIIMS), New Delhi, 2025
  • MRCP (UK) – Part 2, Royal Colleges of Physicians of the United Kingdom
  • ESCMID Global Top 50 Observership, Oxford University Hospitals, United Kingdom, 2024
  • Global Investigator Award, LMCE 2022, Seoul, South Korea
  • ANRF-ITS Grant, Government of India, for IDWeek, Los Angeles, USA, 2024
  • Resource Person, Contagion, 2026
  • Guest Speaker, LTSICON, 2025
  • Resource Person Honour, ASPICON 2021 (Antimicrobial Stewardship)
  • Pan & Basak Memorial Award for Anatomy, Medical College Kolkata, 2013
  • Fellowship & Membership

  • Clinical Infectious Diseases Society Of India
  • European Society Of Clinical Microbiology & Infectious Diseases
  • Infectious Disease Society Of America
  • Delhi Medical Association
  • Field of Expertise

  • Pyrexia of unknown origin
  • Bone & Joint Infections
  • Transplant Infections
  • HIV-AIDS
  • Primary Immunodeficiencies
  • Adult Vaccination
  • Travel Medicine
  • Chemo-Immuno prophylaxis
  • Anti-Microbial Stewardship
  • Hospital acquired infections
  • Hospital Infection Control
  • Sexually Transmitted Diseases
  • Tuberculosis
  • Viral Infections
  • Fungal Infections
  • Languages Spoken

  • Hindi
  • English
  • Bengali
  • Talks & Publications

  • The Utility of Galactomannan and PCR Assays in BAL for Diagnosis of Chronic Pulmonary Aspergillosis, Chowdhury M, Singh G, et al. Mycopathologia, 2023, 188(6): 1041–1053.
  • Efficacy of LD Bio Aspergillus ICT Lateral Flow Assay for Serodiagnosis of Chronic Pulmonary Aspergillosis, Ray A,Chowdhury M, et al. Journal of Fungi (Basel), 2022, 8(4): 400.
  • Clinical predictors of long COVID-19 and phenotypes of mild COVID-19 at a tertiary care centre in India, Chopra N,Chowdhury M, et al. Drug Discoveries & Therapeutics, 2021, 15(3): 156–161.
  • Clinicomicrobiological profile of patients with Stenotrophomonas maltophilia infections, Arunan B, Priyadarshi M, Chowdhary M, Chowdhury S, Mohapatra S, Sood S, Das BK, Wig N, Soneja M. Indian Journal of Medical Microbiology, 2026, 63, 101200. doi:10.1016/j.ijmmb.2026.101200
  • Acanthamoeba meningoencephalitis causing secondary HLH in an immunocompetent patient: a first case report,Chowdhury M, Prakash PR, et al. Journal of the Royal College of Physicians of Edinburgh, 2023, 53(1): 23–26.
  • COVID-19: Immunology & Therapeutics, Chowdhury M, Pant S, Mahishi N, Soneja M, Wig N. COVID-19 Immunology and Therapeutics, Meditropics, 2025.
  • Contributor – Gastrointestinal TB Section, WHO Training Module on Extrapulmonary Tuberculosis, World Health Organization
  • Overview

  • Dr. Mohit Chowdhury is a highly qualified and dedicated specialist in the field of Infectious Diseases, Adult Immunization, and Travel Medicine. He laid the foundation of his medical career at the historic Medical College, Kolkata, where he earned his MBBS degree in 2018. Demonstrating a deep commitment to clinical excellence, he went on to pursue his advanced super-specialization, earning a prestigious DM in Infectious Diseases from the premier All India Institute of Medical Sciences (AIIMS), New Delhi, in 2025. Registered with the Delhi Medical Council since 2019, Dr. Chowdhury brings cutting-edge clinical training and a compassionate approach to patient care.

  • Dr. Chowdhury specializes in diagnosing, managing, and treating a wide spectrum of complex infectious diseases, ranging from acute seasonal infections to chronic, drug-resistant pathogens. With advanced training from AIIMS, he is highly skilled in navigating challenging clinical cases, including healthcare-associated infections, fungal diseases, and infections in immunocompromised individuals. In addition to treatment, he is a strong advocate for preventive healthcare, offering specialized consultations in adult immunization to protect individuals against preventable diseases.

  • Recognizing the complexities of global travel, Dr. Chowdhury also excels in travel medicine, providing essential pre-travel counseling, personalized vaccination plans, and post-travel health evaluations to safeguard travelers heading to diverse geographical regions. His practice combines the latest scientific research with an empathetic, patient-first philosophy, ensuring that each individual receives a comprehensive and tailored management plan.

  • Beyond direct patient care, Dr. Chowdhury is deeply invested in promoting antimicrobial stewardship, helping to combat the global threat of drug resistance by ensuring the rational and judicious use of antibiotics. His rigorous academic background and extensive hands-on residency experience in India's leading tertiary care facility enable him to manage complex outpatient consultations as well as critical ICU-level infectious emergencies with equal precision. Dr. Chowdhury remains committed to improving public health and helping his patients navigate complex health challenges with confidence, scientific clarity, and unmatched clinical dedication.

    Talks & Publications

  • The Utility of Galactomannan and PCR Assays in BAL for Diagnosis of Chronic Pulmonary Aspergillosis, Chowdhury M, Singh G, et al. Mycopathologia, 2023, 188(6): 1041–1053.
  • Efficacy of LD Bio Aspergillus ICT Lateral Flow Assay for Serodiagnosis of Chronic Pulmonary Aspergillosis, Ray A,Chowdhury M, et al. Journal of Fungi (Basel), 2022, 8(4): 400.
  • Clinical predictors of long COVID-19 and phenotypes of mild COVID-19 at a tertiary care centre in India, Chopra N,Chowdhury M, et al. Drug Discoveries & Therapeutics, 2021, 15(3): 156–161.
  • Clinicomicrobiological profile of patients with Stenotrophomonas maltophilia infections, Arunan B, Priyadarshi M, Chowdhary M, Chowdhury S, Mohapatra S, Sood S, Das BK, Wig N, Soneja M. Indian Journal of Medical Microbiology, 2026, 63, 101200. doi:10.1016/j.ijmmb.2026.101200
  • Acanthamoeba meningoencephalitis causing secondary HLH in an immunocompetent patient: a first case report,Chowdhury M, Prakash PR, et al. Journal of the Royal College of Physicians of Edinburgh, 2023, 53(1): 23–26.
  • COVID-19: Immunology & Therapeutics, Chowdhury M, Pant S, Mahishi N, Soneja M, Wig N. COVID-19 Immunology and Therapeutics, Meditropics, 2025.
  • Contributor – Gastrointestinal TB Section, WHO Training Module on Extrapulmonary Tuberculosis, World Health Organization
  • Overview

  • Dr. Mohit Chowdhury is a highly qualified and dedicated specialist in the field of Infectious Diseases, Adult Immunization, and Travel Medicine. He laid the foundation of his medical career at the historic Medical College, Kolkata, where he earned his MBBS degree in 2018. Demonstrating a deep commitment to clinical excellence, he went on to pursue his advanced super-specialization, earning a prestigious DM in Infectious Diseases from the premier All India Institute of Medical Sciences (AIIMS), New Delhi, in 2025. Registered with the Delhi Medical Council since 2019, Dr. Chowdhury brings cutting-edge clinical training and a compassionate approach to patient care.

  • Dr. Chowdhury specializes in diagnosing, managing, and treating a wide spectrum of complex infectious diseases, ranging from acute seasonal infections to chronic, drug-resistant pathogens. With advanced training from AIIMS, he is highly skilled in navigating challenging clinical cases, including healthcare-associated infections, fungal diseases, and infections in immunocompromised individuals. In addition to treatment, he is a strong advocate for preventive healthcare, offering specialized consultations in adult immunization to protect individuals against preventable diseases.

  • Recognizing the complexities of global travel, Dr. Chowdhury also excels in travel medicine, providing essential pre-travel counseling, personalized vaccination plans, and post-travel health evaluations to safeguard travelers heading to diverse geographical regions. His practice combines the latest scientific research with an empathetic, patient-first philosophy, ensuring that each individual receives a comprehensive and tailored management plan.

  • Beyond direct patient care, Dr. Chowdhury is deeply invested in promoting antimicrobial stewardship, helping to combat the global threat of drug resistance by ensuring the rational and judicious use of antibiotics. His rigorous academic background and extensive hands-on residency experience in India's leading tertiary care facility enable him to manage complex outpatient consultations as well as critical ICU-level infectious emergencies with equal precision. Dr. Chowdhury remains committed to improving public health and helping his patients navigate complex health challenges with confidence, scientific clarity, and unmatched clinical dedication.

  • Fellowship & Membership

  • Clinical Infectious Diseases Society Of India
  • European Society Of Clinical Microbiology & Infectious Diseases
  • Infectious Disease Society Of America
  • Delhi Medical Association
  • Field of Expertise

  • Pyrexia of unknown origin
  • Bone & Joint Infections
  • Transplant Infections
  • HIV-AIDS
  • Primary Immunodeficiencies
  • Adult Vaccination
  • Travel Medicine
  • Chemo-Immuno prophylaxis
  • Anti-Microbial Stewardship
  • Hospital acquired infections
  • Hospital Infection Control
  • Sexually Transmitted Diseases
  • Tuberculosis
  • Viral Infections
  • Fungal Infections
  • Languages Spoken

  • Hindi
  • English
  • Bengali
  • Awards & Achievements

  • Gold Medalist – DM (Infectious Diseases), All India Institute of Medical Sciences (AIIMS), New Delhi, 2025
  • MRCP (UK) – Part 2, Royal Colleges of Physicians of the United Kingdom
  • ESCMID Global Top 50 Observership, Oxford University Hospitals, United Kingdom, 2024
  • Global Investigator Award, LMCE 2022, Seoul, South Korea
  • ANRF-ITS Grant, Government of India, for IDWeek, Los Angeles, USA, 2024
  • Resource Person, Contagion, 2026
  • Guest Speaker, LTSICON, 2025
  • Resource Person Honour, ASPICON 2021 (Antimicrobial Stewardship)
  • Pan & Basak Memorial Award for Anatomy, Medical College Kolkata, 2013

FAQ's

Patients visit Dr. Mohit Chowdhury, a leading Consultant - Infectious Diseases at Manipal Hospitals Dwarka - Delhi NCR, for expert care and advanced treatments. Known for accurate diagnoses and patient centric care, Dr. Mohit Chowdhury is a trusted choice for exceptional medical support.

You’re on Our Indian Website

Visit the Global site for International patient services

Need Assistance?
'Click' to chat with us
Chat with us